Preventing Postoperative Atrial Fibrillation: Is There One Best Option?

Conti, Vincent R.

doi:10.1053/j.semtcvs.2018.02.015

Cited by 1 publication

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…В литературе обсуждается роль различных показателей воспаления, маркеров окислительного стресса, тропонина, натрийуретического пептида в развитии этой аритмии [1]. По данным литературы тактика ведения пациентов с целью профилактики развития послеоперационной ФП включала в себя назначение антиаритмических препаратов (в частности, амиодарона), сердечных гликозидов, бета-адреноблокаторов, антагонистов кальция, которые в некоторых случаях могли спровоцировать развитие гипотензии, брадикардии и даже атриовентрикулярной блокады [2,3]. Применение омега-3 полиненасыщенных жирных кислот (ПНЖК) для предотвращения новых случаев послеоперационной ФП демонстрирует противоречивые результаты [4,5].…”

Section: омега-3 полиненасыщенные жирные кислоты: значение в профилак...unclassified

Omega-3 Polyunsaturated Fatty Acids: the Role in Prevention of Atrial Fibrillation in Patients with Coronary Artery Disease after Coronary Artery Bypass Graft Surgery

Rubanenko

Shchukin

Лимарева

et al. 2022

Racionalʹnaâ farmakoterapiâ v kardiologii

View full text Add to dashboard Cite

Aim. To estimate the role of omega-3 polyunsaturated fatty acids (PUFAs) administration in atrial fibrillation (AF) prevention after planned coronary artery bypass graft (CABG) surgery.Material and Methods. Studied were 306 patients divided into two groups: patients of group I didn’t receive PUFAs (158 patients, 82.7% males) and patients of group II received PUFAs (148 patients, 89.3% males). PUFAs were prescribed in daily dose 2000 mg 5 days before surgery and in daily dose 1000 mg in postoperative period during 21 days.Results. Postoperative AF (POAF) occurred in 29.7% patients in group I and in 16.9% patients in group II (р=0.009). We found that after CABG in patients of the I group median IL-6 level was 39.3% higher (p=0.001), interleukin-10 – 20.2% higher (p=0.01), superoxide dismutase – 78.9% higher (р<0.001), malondialdehyde – 33.8% higher (p=0.03), docosahexaenoic acid – 31.8% lower (p=0.01) and omega-3 index – 43.4% lower (p=0.04) than in patients of the II group.According to multivariate regression analysis we found significant association between the factors of inflammation, oxidative stress and the risk POAF development.Conclusions. In patients who took PUFAs, we found less activation of inflammation, oxidative stress, the increasing of docosahexaenoic acid and omega-3 index accompanied by the decreasing of POAF development rates up to 12.8%.

show abstract